Specialty
Hospital Medicine & Nursing devices
Last checked: Nov 19, 2026Source: openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
2,786
510(k), De Novo and PMA
Decisions, last 36 months
535
Recruiting device trials
92
Industry sponsored
Adverse event reports
336,274
Received Nov 1, 2025 to Nov 19, 2026
Latest FDA decisions
The 8 newest. A specialty is the FDA review panel, or a list of product codes for a narrower view.
- CleanBreak510(k)
K260478 · Decided Nov 6, 2026 · 266 days after receipt
Device type: Intravenous Catheter Force-Activated Separation Device. (QOI) · Hospital Medicine & Nursing
K260631 · Decided Nov 5, 2026 · 252 days after receipt
Device type: Catheter, Intravascular, Therapeutic, Short-Term Less Than 30 Days (FOZ) · Hospital Medicine & Nursing
West Pharma. Services IL, Ltd.
K260730 · Decided Nov 5, 2026 · 245 days after receipt
Device type: Set, I.V. Fluid Transfer (LHI) · Hospital Medicine & Nursing
Zhejiang Fomos Medical Technology Co., Ltd.
K260354 · Decided Oct 30, 2026 · 269 days after receipt
Device type: Sterilizer, Steam (FLE) · Hospital Medicine & Nursing
K253508 · Decided Oct 29, 2026 · 360 days after receipt
Device type: Polymer Patient Examination Glove (LZA) · Hospital Medicine & Nursing
K260427 · Decided Oct 29, 2026 · 261 days after receipt
Device type: Ultraviolet Radiation Disinfection Chamber Device (SCS) · Hospital Medicine & Nursing
K263530 · Decided Oct 29, 2026 · 30 days after receipt
Device type: Sterilizer, Chemical (MLR) · Hospital Medicine & Nursing
K260822 · Decided Oct 28, 2026 · 229 days after receipt
Device type: Qualitative Cleaning Process Protein Indicator (SDC) · Hospital Medicine & Nursing
FDA decisions per month
Last 36 months, by decision date and pathway.
- 510(k)
- De Novo
- PMA
View as table
| Month | 510(k) | De Novo | PMA |
|---|---|---|---|
| Dec 23 | 19 | 1 | 0 |
| Jan 24 | 13 | 0 | 0 |
| Feb 24 | 13 | 0 | 0 |
| Mar 24 | 21 | 0 | 0 |
| Apr 24 | 16 | 1 | 0 |
| May 24 | 16 | 1 | 0 |
| Jun 24 | 21 | 0 | 0 |
| Jul 24 | 14 | 1 | 0 |
| Aug 24 | 13 | 2 | 0 |
| Sep 24 | 21 | 0 | 0 |
| Oct 24 | 17 | 0 | 0 |
| Nov 24 | 10 | 1 | 0 |
| Dec 24 | 14 | 0 | 0 |
| Jan 25 | 14 | 0 | 0 |
| Feb 25 | 17 | 0 | 0 |
| Mar 25 | 14 | 1 | 0 |
| Apr 25 | 22 | 1 | 0 |
| May 25 | 18 | 0 | 0 |
| Jun 25 | 20 | 0 | 0 |
| Jul 25 | 21 | 0 | 0 |
| Aug 25 | 15 | 0 | 0 |
| Sep 25 | 6 | 0 | 0 |
| Oct 25 | 15 | 0 | 0 |
| Nov 25 | 10 | 0 | 0 |
| Dec 25 | 16 | 1 | 0 |
| Jan 26 | 12 | 0 | 0 |
| Feb 26 | 12 | 0 | 0 |
| Mar 26 | 7 | 0 | 0 |
| Apr 26 | 19 | 0 | 0 |
| May 26 | 6 | 1 | 0 |
| Jun 26 | 19 | 0 | 0 |
| Jul 26 | 11 | 0 | 0 |
| Aug 26 | 11 | 1 | 0 |
| Sep 26 | 13 | 0 | 0 |
| Oct 26 | 14 | 0 | 0 |
| Nov 26 | 3 | 0 | 0 |
Recruiting device trials
Industry-sponsored device trials that are recruiting now, most recently updated first.
- Interventional Clinical Trial Evaluating COVER PATCH CAPTEUR PROTECT Support Solutions for Continuous Glucose Monitoring Sensors in Patients With DiabetesPivotal-lookingRecruiting
CAPTEUR PROTECTNot on our public-company list
NCT07018180 · 194 participants (planned) · Start Dec 5, 2025
Device: Use of COVER patchs for continuous glucose monitoring sensor · For: Diabetes
Sites: Bron, France; Corbeil-Essonnes, France; Grenoble, France · 10 sites in all
Rhaeos, Inc.Not on our public-company list
NCT07815314 · 85 participants (planned) · Start Sep 23, 2026 · Primary completion Jan 2027
Device: Rhaeos Shunt Monitoring System (RSMS); ShuntCheck III · For: Hydrocephalus
Sites: Chicago, Illinois; Baltimore, Maryland; Williamsville, New York · 4 sites in all
- Dual-Targeting CAR-NK Cell Therapy for Recurrent/Progressive Glioblastoma and High-Grade GliomaRecruiting
Beijing BiotechNot on our public-company list
NCT07480941 · 36 participants (planned) · Start Feb 2, 2026 · Primary completion Feb 18, 2027
Device: Intracranial catheter/reservoir for locoregional delivery · For: Glioblastoma; High-grade Glioma; Malignant Glioma and 2 more
Sites: Shenzhen, China
Beijing BiotechNot on our public-company list
NCT07551336 · 36 participants (planned) · Start Mar 2, 2026 · Primary completion Apr 14, 2027
Device: Intracranial catheter/reservoir for locoregional delivery · For: Malignant Glioma; High-Grade Gliomas; Glioblastoma and 2 more
Sites: Shenzhen, China
- VT Ablation in the iCMRRecruiting
Imricor Medical SystemsNot on our public-company list
NCT05543798 · 64 participants (planned) · Start Apr 10, 2025 · Primary completion Jul 2027
Device: Vision-MR Ablation Catheter 2.0 · For: Ventricular Tachycardia
Sites: Leipzig, Germany; Amsterdam, Netherlands; The Hague, Netherlands
Biosense Webster, Inc.Public (JNJ)
NCT07227532 · 276 participants (planned) · Start Oct 21, 2025 · Primary completion Dec 31, 2030
Device: Pulsed Field Ablation by VARIPULSE Catheter with TRUPULSE Generator · For: Atrial Fibrillation
Sites: Phoenix, Arizona; Tucson, Arizona; Fountain Valley, California · 25 sites in all
How new technology gets paid for
Recent Medicare coverage decisions that touch this specialty.
Reports received
336,274
Received Nov 1, 2025 to Nov 19, 2026. Includes 744 of another or unstated type.
Malfunction reports
255,171
76% of reports
Injury reports
79,477
24% of reports
Death reports
882
0.3% of reports
Adverse event reports received per month
By the date FDA received each report. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Nov 25 | 9,038 | 1,388 | 44 | 0 |
| Dec 25 | 8,912 | 928 | 54 | 4 |
| Jan 26 | 8,664 | 811 | 36 | 2 |
| Feb 26 | 8,904 | 1,000 | 33 | 5 |
| Mar 26 | 15,607 | 2,837 | 61 | 2 |
| Apr 26 | 21,838 | 8,628 | 30 | 8 |
| May 26 | 19,506 | 7,313 | 35 | 3 |
| Jun 26 | 22,793 | 10,601 | 373 | 1 |
| Jul 26 | 29,396 | 10,172 | 39 | 103 |
| Aug 26 | 38,160 | 12,582 | 72 | 219 |
| Sep 26 | 37,823 | 11,165 | 66 | 260 |
| Oct 26 | 34,530 | 12,052 | 39 | 137 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types with the most reports
Widely used device types get more reports. This is not a ranking of safety.
- Pump, Infusion (FRN)52,387
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.